Double attack on liver cancer: does adding RFA to TACE improve survival?
Disease control
Completed
This phase 3 trial tested whether adding radiofrequency ablation (RFA) to standard transarterial chemoembolization (TACE) improves outcomes for people with intermediate-stage liver cancer. 241 participants with 2-10 liver tumors were randomly assigned to receive either TACE alone…
Phase: PHASE3 • Sponsor: Ming Zhao • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC